Cargando…
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)
The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, diffic...
Autores principales: | Mylonakis, Eleftherios, Lutaakome, Joseph, Jain, Mamta K., Rogers, Angela J., Moltó, José, Benet, Susana, Mourad, Ahmad, Files, D. Clark, Mugerwa, Henry, Kityo, Cissy, Kiweewa, Francis, Nalubega, Mary Grace, Kitonsa, Jonathan, Nabenkema, Evelyn, Murray, Daniel D., Braun, Dominique, Kamel, Dena, Higgs, Elizabeth S., Hatlen, Timothy J., Kan, Virginia L., Sanchez, Adriana, Tierney, John, Denner, Eileen, Wentworth, Deborah, Babiker, Abdel G., Davey, Victoria J., Gelijns, Annetine C., Matthews, Gail V., Thompson, B. Taylor, Lane, H. Clifford, Neaton, James D., Lundgren, Jens D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373164/ https://www.ncbi.nlm.nih.gov/pubmed/35963234 http://dx.doi.org/10.1016/j.medj.2022.07.003 |
Ejemplares similares
-
What Does Acute Respiratory Distress Syndrome Mean during the COVID-19 Pandemic?
por: Brown, Samuel M., et al.
Publicado: (2021) -
The Emergence of Population Health in US Academic Medicine: A Qualitative Assessment
por: Gourevitch, Marc N., et al.
Publicado: (2019) -
Facilitated transition in HIV drug trial closure: A conceptual model for HIV post-trial care
por: Nalubega, Sylivia, et al.
Publicado: (2021) -
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults
por: Lamorde, Mohammed, et al.
Publicado: (2012) -
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)
por: Murray, Daniel D., et al.
Publicado: (2021)